Insurers Battle Families Over Costly Drug for Fatal Disease

The case of Exondys 51 poses emotionally charged issues for families of young boys with a rare illness, who are fighting companies to get coverage for an expensive drug approved on a lower bar of proof.
By KATIE THOMAS from NYT Health http://ift.tt/2s1g0DT
via IFTTT
Drugs (Pharmaceuticals), Health Insurance and Managed Care
Source The New York Times
Làm đẹp Blog 247